In Food Programs Restructuring, US FDA Has Designs On Clear Priorities, Chain Of Command

Following reviews prompted largely by formula supply crisis, FDA will move Center for Food Safety and Applied Nutrition and commissioner’s Office of Food Programs and Response to Human Foods Program headed by deputy commissioner. Office of Regulatory Affairs' structure also changing “to support the FDA organization as a whole,” says Commissioner Califf.

• Source: Shutterstock

Recommendations from experts US Food and Drug Administration Commissioner Robert Califf turned to when he took the post a year ago has led to a proposed restructuring of the agency’s human food programs, including closer alignment with its field inspections office.

Following reviews prompted largely by the infant formula supply crisis which became known when Califf began his second stint as commissioner in February 2022, the Center for Food Safety and Applied Nutrition and the commissioner’s Office of Food Programs and Response will move to the

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Supply Chain

More from HBW Insight

Venture Life Focuses On CHC As It Offloads CDMO

 
• By 

UK-based Venture Life is divesting its CDMO business and some non-core products to focus its attention on growing its consumer health operation.

New Zealand Could Become First Country To Offer Gout Drug Allopurinol OTC

 
• By 

At the second attempt, New Zealand’s Medicines Classification Committee supported the Rx-to-OTC switch of allopurinol (100mg and 300mg) for people suffering from gout by specifically trained pharmacists.

Mitigating Tariff Impacts, Kenvue Adjusts Outlook

 

“The situation has evolved considerably” since Kenvue gave its initial full-year outlook in February, “and remains quite fluid,” says president and CEO Thibaut Mongon as firm reports Q1 net sales decreasing 3.9% to $3.7bn